These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 17440082

  • 1. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
    Wang Y, Thakur A, Sun Y, Wu J, Biliran H, Bollig A, Liao DJ.
    Cancer Res; 2007 Apr 15; 67(8):3698-707. PubMed ID: 17440082
    [Abstract] [Full Text] [Related]

  • 2. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ, Natarajan G, Deming SL, Jamerson MH, Johnson M, Chepko G, Dickson RB.
    Oncogene; 2000 Mar 02; 19(10):1307-17. PubMed ID: 10713672
    [Abstract] [Full Text] [Related]

  • 3. Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis.
    Li YJ, Song R, Korkola JE, Archer MC, Ben-David Y.
    Oncogene; 2003 May 29; 22(22):3452-62. PubMed ID: 12776197
    [Abstract] [Full Text] [Related]

  • 4. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV, Adachi S, Li SF, Mateyak MK, Wei S, Sedivy JM.
    Cancer Res; 2001 Feb 01; 61(3):1178-86. PubMed ID: 11221849
    [Abstract] [Full Text] [Related]

  • 5. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
    Chen H, Liu J, Zhao CQ, Diwan BA, Merrick BA, Waalkes MP.
    Toxicol Appl Pharmacol; 2001 Sep 15; 175(3):260-8. PubMed ID: 11559025
    [Abstract] [Full Text] [Related]

  • 6. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.
    Sasaki R, Narisawa-Saito M, Yugawa T, Fujita M, Tashiro H, Katabuchi H, Kiyono T.
    Carcinogenesis; 2009 Mar 15; 30(3):423-31. PubMed ID: 19126650
    [Abstract] [Full Text] [Related]

  • 7. Specific protection against breast cancers by cyclin D1 ablation.
    Yu Q, Geng Y, Sicinski P.
    Nature; 2001 Jun 28; 411(6841):1017-21. PubMed ID: 11429595
    [Abstract] [Full Text] [Related]

  • 8. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
    Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J.
    Cancer Res; 2006 Mar 01; 66(5):2544-52. PubMed ID: 16510571
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
    Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB.
    Oncogene; 1993 Dec 01; 8(12):3447-57. PubMed ID: 8247550
    [Abstract] [Full Text] [Related]

  • 10. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG, van Bragt MP, Schuuring-Scholtes E, van der Ploeg JC, van Krieken JH, Kluin PM, Schuuring E.
    BMC Cancer; 2006 Mar 14; 6():58. PubMed ID: 16536875
    [Abstract] [Full Text] [Related]

  • 11. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.
    Amundadottir LT, Nass SJ, Berchem GJ, Johnson MD, Dickson RB.
    Oncogene; 1996 Aug 15; 13(4):757-65. PubMed ID: 8761297
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cyclin d1 overexpression sensitizes breast cancer cells to fenretinide.
    Pirkmaier A, Yuen K, Hendley J, O'Connell MJ, Germain D.
    Clin Cancer Res; 2003 May 15; 9(5):1877-84. PubMed ID: 12738746
    [Abstract] [Full Text] [Related]

  • 15. Immortalized mammary epithelial cells overexpressing protein kinase C gamma acquire a malignant phenotype and become tumorigenic in vivo.
    Mazzoni E, Adam A, Bal de Kier Joffe E, Aguirre-Ghiso JA.
    Mol Cancer Res; 2003 Aug 15; 1(10):776-87. PubMed ID: 12939403
    [Abstract] [Full Text] [Related]

  • 16. E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells.
    Al Moustafa AE, Foulkes WD, Benlimame N, Wong A, Yen L, Bergeron J, Batist G, Alpert L, Alaoui-Jamali MA.
    Oncogene; 2004 Jan 15; 23(2):350-8. PubMed ID: 14724563
    [Abstract] [Full Text] [Related]

  • 17. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells.
    Zhou P, Jiang W, Zhang YJ, Kahn SM, Schieren I, Santella RM, Weinstein IB.
    Oncogene; 1995 Aug 03; 11(3):571-80. PubMed ID: 7630641
    [Abstract] [Full Text] [Related]

  • 18. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
    Casimiro M, Rodriguez O, Pootrakul L, Aventian M, Lushina N, Cromelin C, Ferzli G, Johnson K, Fricke S, Diba F, Kallakury B, Ohanyerenwa C, Chen M, Ostrowski M, Hung MC, Rabbani SA, Datar R, Cote R, Pestell R, Albanese C.
    Cancer Res; 2007 May 01; 67(9):4364-72. PubMed ID: 17483350
    [Abstract] [Full Text] [Related]

  • 19. Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors.
    Ling H, Sylvestre JR, Jolicoeur P.
    Oncogene; 2010 Aug 12; 29(32):4543-54. PubMed ID: 20562911
    [Abstract] [Full Text] [Related]

  • 20. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.
    Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV.
    Nature; 1994 Jun 23; 369(6482):669-71. PubMed ID: 8208295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.